Market Cap: $398.76M
AI
Altimmune, Inc.
ALT
NASDAQ (NASDAQ Global Market)USD
Market Cap: $398.76M
Wegovy’s Higher Dose Launch: A Strategic Response in the Obesity Market In a landscape increasingly dominated by effective obesity treatments, Novo Nordisk aims to reclaim its position with the upcomi…
### Altimmune Reports Strong Earnings and Strategic Initiatives at Q4 Earnings Call Altimmune (NASDAQ:ALT) announces notable financial growth as it reports its fourth-quarter earnings, showcasing a su…
Altimmune’s Strategic Growth and Pipeline Advancements Take Center Stage Altimmune, a key player in the biotechnology sector, announces substantial developments in its financial performance during its…
Altimmune Secures Breakthrough Therapy Designation for Pemvidutide, Paving the Way for Innovative Obesity Treatment Altimmune, Inc. (NASDAQ:ALT) reaches a significant milestone with the U.S. Food and…
Altimmune's Focus on Innovative Therapeutics Amid Market Optimism Altimmune, a clinical-stage biopharmaceutical company, continues to advance its pipeline of immunotherapeutics designed to address sig…
Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide: A Game Changer in Obesity Treatment Altimmune, Inc. (NASDAQ:ALT) achieves a significant milestone with the U.S. Food and Drug A…
Altimmune’s Pemvidutide Receives FDA Breakthrough Therapy Designation Altimmune, Inc. achieves a significant milestone with the recent announcement that the U.S. Food and Drug Administration (FDA) has…
Altimmune's Pemvidutide Trial Results Mark a Significant Milestone in Obesity Treatment Altimmune Inc. announces promising topline results from the IMPACT Phase 2b trial of pemvidutide, a novel drug c…
Altimmune's Pemvidutide Trial Yields Promising Results in Obesity Management Altimmune Inc. has recently announced encouraging topline results from its Phase 2b trial of pemvidutide, a novel therapeut…
MLTT Partners with IC360 and ALT Sports Data to Introduce Regulated Wagering In a significant development for the burgeoning sport of table tennis in the United States, Major League Table Tennis (MLTT…
MLTT Partners with Integrity Compliance 360 and ALT Sports Data to Enhance Integrity in Sports Wagering Major League Table Tennis (MLTT) forges a significant partnership with Integrity Compliance 360…
MLTT Partners with IC360 and ALT Sports Data to Introduce Regulated Wagering Major League Table Tennis (MLTT) announces a significant development in the world of professional sports by forming strateg…
### Meta's Settlement: A Turning Point in Corporate Privacy Practices In a significant legal development, Mark Zuckerberg and several current and former directors of Meta Platforms have reached a $190…
Altimmune's Strategic Position in the Biopharmaceutical Landscape Altimmune, a clinical-stage biopharmaceutical company, is currently at the forefront of developing innovative therapies that target in…
Transforming Mobility: The Electric Wheelchair Market’s Promising Future The electric wheelchair market stands at the forefront of a transformative era in personal mobility, driven by demographic chan…
Diverse Analyst Perspectives Shape Altimmune's Future Outlook Altimmune, a biotechnology company focused on developing innovative therapies for infectious diseases and immune-related disorders, recent…
Navigating Diverse Perspectives in Biotechnology: Altimmune's Analyst Insights Altimmune, a biopharmaceutical company specializing in immune-modulating therapies, finds itself at a pivotal juncture as…
Altimmune Faces Class Action Lawsuit Over Pemvidutide Trial Results Altimmune, Inc. confronts a significant legal challenge as the Schall Law Firm announces a class action lawsuit against the biopharm…
Altimmune Faces Legal Scrutiny Over Pemvidutide Trial Results Altimmune, Inc. (NASDAQ: ALT) is currently navigating a challenging landscape as it confronts legal actions stemming from disappointing re…
Altimmune Faces Legal Scrutiny Over Phase 2b Trial Results Altimmune, Inc., a biotechnology company specializing in immune therapies, is currently under investigation due to allegations stemming from…
Altimmune Faces Class Action Lawsuit Over Pemvidutide Misrepresentation Altimmune, Inc. is currently embroiled in a class action lawsuit initiated by The Schall Law Firm, which accuses the biopharmace…
Altimmune Faces Class Action Lawsuit Over Pemvidutide Trial Results Altimmune, Inc., a clinical-stage biopharmaceutical company specializing in treatments for obesity and liver disease, is currently e…
Altimmune Faces Class Action Lawsuit Over Misrepresentation of Trial Data Altimmune, Inc. finds itself embroiled in a significant legal challenge as Rosen Law Firm announces a class action lawsuit on…
Altimmune Faces Legal Challenges Over Trial Results In recent developments, Altimmune, Inc. grapples with significant legal repercussions following disappointing results from its IMPACT Phase 2b MASH…
Altimmune Faces Legal Scrutiny Amid Disappointing Trial Results Altimmune, Inc., a clinical-stage biopharmaceutical company focused on therapies for obesity and liver diseases, is currently under inve…